Molnupiravir will be offered to at-risk patients who already have the coronavirus.
It is not a substitute for the COVID-19 vaccine, UK authorities said.
Vanderbilt Medical Center's role in COVID antiviral pill research
NewsChannel 5 Nashville - Termin
The FDA said Friday an experimental antiviral pill from drug company Merck is effective against COVID-19.
